The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability

Mol Oncol. 2008 Apr;1(4):431-9. doi: 10.1016/j.molonc.2007.08.002. Epub 2007 Aug 19.

Abstract

The apoptosis linked gene-2 (ALG-2), discovered as a proapoptotic calcium binding protein, has recently been found upregulated in lung cancer tissue indicating that this protein may play a role in the pathology of cancer cells and/or may be a tumor marker. Using immunohistochemistry on tissue microarrays we analysed the expression of ALG-2 in 7371 tumor tissue samples of various origin as well as in 749 normal tissue samples. Most notably, ALG-2 was upregulated in mesenchymal tumors. No correlation was found between ALG-2 staining intensity and survival of patients with lung, breast or colon cancer. siRNA mediated ALG-2 downregulation led to a significant reduction in viability of HeLa cells indicating that ALG-2 may contribute to tumor development and expansion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics*
  • Apoptosis Regulatory Proteins / genetics*
  • Breast Neoplasms
  • Calcium-Binding Proteins / genetics*
  • Cell Survival / genetics
  • Colonic Neoplasms
  • Down-Regulation / drug effects
  • Gene Expression Regulation, Neoplastic*
  • HeLa Cells
  • Humans
  • Lung Neoplasms
  • Mesoderm / pathology
  • Neoplasms / genetics
  • Neoplasms / pathology*
  • RNA, Small Interfering / pharmacology
  • Tissue Array Analysis

Substances

  • Apoptosis Regulatory Proteins
  • Calcium-Binding Proteins
  • PDCD6 protein, human
  • RNA, Small Interfering